Objective: To assess the current status of thyroid function and investigate selected associated factors among overweight/obese patients with type 2 diabetes mellitus (T2DM) at the National Hospital of Endocrinology. Patients and Methods: An analytical cross-sectional study was conducted on 320 overweight/obese patients with T2DM. Results: The mean age of the study population was 60.6 ± 11.8 years; 59.7% were aged ≥60 years, and women accounted for 69.7%. The mean body mass index (BMI) was 25.4 ± 2.1 kg/m². The prevalence of thyroid dysfunction was 28.4% (91/320), including secondary hypothyroidism in 10.9%, subclinical hyperthyroidism in 7.2%, subclinical hypothyroidism in 5.9%, overt primary hyperthyroidism in 3.1%, and overt primary hypothyroidism in 1.3%. Age, sex, and BMI categories were not significantly associated with thyroid dysfunction. Patients with hypothyroidism had significantly higher total cholesterol levels. Free thyroxine (FT4) was inversely correlated with total cholesterol (r = −0.42; p = 0.001), whereas thyroid-stimulating hormone (TSH) showed a weak positive correlation with fasting plasma glucose (r = 0.14; p = 0.012). In multivariable logistic regression analysis, total cholesterol was the only factor independently associated with hypothyroidism (OR = 1.89; 95% CI: 1.45–2.46; p < 0.001). Conclusion: Thyroid dysfunction is common among overweight/obese patients with type 2 diabetes. Routine thyroid function assessment should be considered in this high-risk metabolic population, particularly when lipid control is suboptimal, as total cholesterol was identified as an independent factor associated with hypothyroidism in the multivariable analysis.
THYROID FUNCTION STATUS IN OVERWEIGHT AND OBESE PATIENTS WITH TYPE 2 DIABETES AT THE NATIONAL HOSPITAL OF ENDOCRINOLOGY
0
Views
0
Downloads
Abstract
Keywords
type 2 diabetes, overweight, obesity, thyroid dysfunction, hypothyroidism, TSH, FT4.
References
[1]
[1] Hadgu R, et al. Prevalence of thyroid dysfunction and associated factors among adult type 2 diabetes mellitus patients, 2000-2022: a systematic review and meta-analysis. Systematic Reviews. 2024. DOI: 10.1186/s13643-024-02527-y
Google Scholar
[2]
[2] Khassawneh AH, Al-Mistarehi AH, Zein Alaabdin AM, et al. Prevalence and predictors of thyroid dysfunction among type 2 diabetic patients: a case-control study. International Journal of General Medicine. 2020;13:803-816. DOI: 10.2147/IJGM.S273900
Google Scholar
[3]
[3] Mahdavi M, Amouzegar A, Mehran L, et al. Investigating the prevalence of primary thyroid dysfunction in obese and overweight individuals: Tehran Thyroid Study. BMC Endocrine Disorders. 2021;21:89. DOI: 10.1186/s12902-021-00743-4
Google Scholar
[4]
[4] Sharma B, Chaudhary V, Kumari S, Pal B. Prevalence of thyroid disorders in patients with diabetes and hypertension in India: a systematic review and meta-analysis. Obesity Medicine. 2025;55. 10.1016/j.obmed.2025.100609
Google Scholar
[5]
[5] Biondi B, Kahaly GJ, Robertson RP. Thyroid dysfunction and diabetes mellitus: two closely associated disorders. Endocrine Reviews. 2019;40(3):789-824. DOI: 10.1210/er.2018-00163
Google Scholar
[6]
[6] Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Thyroid. 2012;22(12):1200-1235. DOI: 10.4158/EP12280.GL
Google Scholar
[7]
[7] Nicolaou M, et al. Lipid profile pitfalls in subclinical hypothyroidism: a review of recent evidence. 2024. https://doi.org/10.3390/lipidology1020008
Google Scholar
[8]
[8] Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. PMID: 27521067. DOI: 10.1089/thy.2016.0229
Google Scholar